Skip to content
Back to Guavy Wire
Stocks

Commerzbank Boosts Stake in Biotech Giant Amgen Inc.

Instruments
AMGN
Share

Commerzbank Aktiengesellschaft FI acquired an additional 14,693 shares of Amgen Inc. (NASDAQ:AMGN) in the second quarter, increasing its holdings by 7.5%. This brought the company's total ownership to 209,478 shares, accounting for approximately 1.5% of Commerzbank Aktiengesellschaft FI's portfolio.

The value of these shares was $75,856,000 as of the most recent SEC filing. Amgen Inc. is a global biotechnology company that focuses on discovering, developing, manufacturing and delivering human therapeutic products.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc